Amgen Inc. buy Royal Bank of Canada
Start price
14.06.24
/
50%
€278.00
Target price
14.06.25
€310.92
Performance (%)
-7.41%
End price
15.06.25
€257.40
Summary
This prediction ended on 15.06.25 with a price of €257.40. With a performance of -7.41%, the BUY prediction for Amgen Inc. by Royal_Bank_of_Canada closed slightly in the red. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €8.81 was paid as dividends for this prediction. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -1.185% | -1.185% | 8.681% |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $328.00 to $332.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten